ISRCTN56498577已完成未知
Early External Cephalic Version (ECV) 2 trial
McMaster University Medical Centre (Canada)0 个研究点目标入组 1,460 人开始时间: 2005年4月22日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 1,460
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •1. Women with any breech presentation, aged 18 - 49 years old
- •2. A live singleton foetus
- •3. Gestational age of 33^0/7 - 35^6/7 weeks
排除标准
- •1. Any contraindication to ECV
- •2. Previous participation in the EECV2 Trial
- •3. Any contraindication to early ECV
- •4. Women who wish a vaginal delivery if the foetus remains breech
- •5. Any contraindication to labour or vaginal birth
- •6. Women who wish to deliver by Caesarean Section (CS) if the foetus turns to cephalic
- •7. Women at increased risk of unstable lie
- •Please note that the following exclusion criteria was removed from this list on 06/11/2007:
- •8. Women who plan to move to a non-trial centre prior to delivery
研究者
相似试验
进行中（未招募）
1 期
Phase 2b dose-ranging trial to evaluate delgocitinib cream 1, 3, 8, and 20 mg/g compared to delgocitinib cream vehicle over a 16-week treatment period in adult subjects with chronic hand eczemaChronic hand eczemaMedDRA version: 20.0Level: LLTClassification code 10066695Term: Chronic hand dermatitisSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersMedDRA version: 20.0Level: SOCClassification code 10040785Term: Skin and subcutaneous tissue disordersSystem Organ Class: 10040785 - Skin and subcutaneous tissue disordersEUCTR2018-000900-40-DKEO Pharma A/S250
进行中（未招募）
1 期
First-in-Human Study of IMGC936 in Patients With Advanced Solid TumorsAdvanced Solid TumorsMedDRA version: 20.0Level: LLTClassification code 10079440Term: Non-squamous non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10075566Term: Triple negative breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10056267Term: Gastroesophageal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10061451Term: Colorectal cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: LLTClassification code 10033604Term: Pancreatic cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2021-002264-41-ESImmunoGen, Inc.250
进行中（未招募）
1 期
Study of MGC018 Alone and in Combination with MGA012 in Patients with Advanced Solid TumorsAdvanced Solid TumorsMedDRA version: 20.0 Level: PT Classification code 10067821 Term: Head and neck cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: LLT Classification code 10036921 Term: Prostate carcinoma System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: PT Classification code 10075566 Term: Triple negative breast cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: HLT Classification code 10030052 Term: Ocular melanomas System Organ Class: 100000004853MedDRA version: 20.0 Level: LLT Classification code 10065147 Term: Malignant solid tumor System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0 Level: LLT Classification code 10065252 Term: Solid tumor System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-003555-38-ESMacroGenics, Inc.193
进行中（未招募）
1 期
Study of MGC018 Alone and in Combination with MGA012 in Patients with Advanced Solid TumorsAdvanced Solid TumorsMedDRA version: 21.1Level: PTClassification code 10067821Term: Head and neck cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10036921Term: Prostate carcinomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10075566Term: Triple negative breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: LLTClassification code 10065147Term: Malignant solid tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: LLTClassification code 10065252Term: Solid tumorSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.1Level: PTClassification code 10061873Term: Non-small cell lung cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: LLTClassification code 10040891Term: Skin melanomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2018-003555-38-PLMacroGenics, Inc.182
招募中
1 期
First-in-Human Study of TAK-280 in Participants With Unresectable Locally Advanced or Metastatic Cancernresectable Locally Advanced or Metastatic CancerMedDRA version: 21.0Level: PTClassification code: 10061289Term: Metastatic neoplasm Class: 100000004864CTIS2023-504012-16-00Takeda Development Center Americas Inc.129